ES494690A0 - Un procedimiento para la preparacion de espiro (ciclohexano-1.1'(3'h)-isobenzofuranos) - Google Patents

Un procedimiento para la preparacion de espiro (ciclohexano-1.1'(3'h)-isobenzofuranos)

Info

Publication number
ES494690A0
ES494690A0 ES494690A ES494690A ES494690A0 ES 494690 A0 ES494690 A0 ES 494690A0 ES 494690 A ES494690 A ES 494690A ES 494690 A ES494690 A ES 494690A ES 494690 A0 ES494690 A0 ES 494690A0
Authority
ES
Spain
Prior art keywords
isobenzofuranos
cyclohexane
spiral
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES494690A
Other languages
English (en)
Other versions
ES8106512A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES494690A0 publication Critical patent/ES494690A0/es
Publication of ES8106512A1 publication Critical patent/ES8106512A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
ES494690A 1979-09-06 1980-09-01 Un procedimiento para la preparacion de espiro (ciclohexano-1.1'(3'h)-isobenzofuranos) Expired ES8106512A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/073,055 US4263317A (en) 1979-09-06 1979-09-06 Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s

Publications (2)

Publication Number Publication Date
ES494690A0 true ES494690A0 (es) 1981-07-16
ES8106512A1 ES8106512A1 (es) 1981-07-16

Family

ID=22111440

Family Applications (8)

Application Number Title Priority Date Filing Date
ES494690A Expired ES8106512A1 (es) 1979-09-06 1980-09-01 Un procedimiento para la preparacion de espiro (ciclohexano-1.1'(3'h)-isobenzofuranos)
ES501424A Granted ES501424A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)
ES501421A Expired ES8203083A1 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)
ES501419A Granted ES501419A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzoeuranos)
ES501420A Expired ES8203082A1 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)
ES501422A Granted ES501422A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro(ciclohexano- 1,1'(3'h)-isobenzofuranos)
ES501418A Granted ES501418A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)
ES501423A Granted ES501423A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)

Family Applications After (7)

Application Number Title Priority Date Filing Date
ES501424A Granted ES501424A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)
ES501421A Expired ES8203083A1 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)
ES501419A Granted ES501419A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzoeuranos)
ES501420A Expired ES8203082A1 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)
ES501422A Granted ES501422A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro(ciclohexano- 1,1'(3'h)-isobenzofuranos)
ES501418A Granted ES501418A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)
ES501423A Granted ES501423A0 (es) 1979-09-06 1981-04-15 Un procedimiento para la preparacion de espiro (ciclohexano-1,1'(3'h)-isobenzofuranos)

Country Status (4)

Country Link
US (1) US4263317A (es)
EP (1) EP0027522A1 (es)
JP (1) JPS5645469A (es)
ES (8) ES8106512A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301292A (en) * 1979-09-06 1981-11-17 Hoechst-Roussel Pharmaceuticals, Incorporated 1-[2-(4,5-Dihydro-4,4-dialkyl-2-oxazolyl)phenyl]-4-(dialkylamino)cyclohexanol
US4288623A (en) * 1979-09-06 1981-09-08 Hoechst-Roussel Pharmaceuticals Inc. 1-Aryl-4-amino-cyclohexan-1-ols
US4313959A (en) * 1981-04-27 1982-02-02 Hoechst-Roussel Pharmaceuticals Inc. (Arylmethyl)phenyl-aminocyclohexanols, cyclohexenes and intermediates thereof
US4517311A (en) * 1981-10-19 1985-05-14 Hoechst-Roussel Pharmaceuticals Inc. 2'-Substituted-spiro[benzofuran-2(3H),1'-cycloalkanes] and their analgesic and anti-depressant compositions
US4404221A (en) * 1981-10-19 1983-09-13 Hoechst-Roussel Pharmaceuticals Inc. 2'-Substituted-spiro[benzofuran-2(3H),1'-cyclohexanes] and its pharmaceutical use
US4594435A (en) * 1982-09-13 1986-06-10 Hoechst-Roussel Pharmaceuticals, Inc. Intermediates for 2'-substituted-spiro[benzofuran-2(3H),1'-cycloalkanes]
US5506247A (en) * 1988-04-15 1996-04-09 T Cell Sciences, Inc. Compounds that inhibit complement and/or suppress immune activity
US5366986A (en) * 1988-04-15 1994-11-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
US5173499A (en) * 1988-04-15 1992-12-22 T Cell Sciences, Inc. Compounds which inhibit complement and/or suppress immune activity
US4981980A (en) * 1989-09-14 1991-01-01 Merck & Co., Inc. Drug for treating manic depression
US5239110A (en) * 1992-12-30 1993-08-24 Sterling Winthrop, Inc. Phenylcyclohexanol derivatives as agents for treating CNS disorders
DE19962866A1 (de) 1999-12-24 2001-07-05 Effem Gmbh Verfahren zum Herstellen gefüllter Nahrungsmittel-Hohlkörper
US6453106B1 (en) 2000-06-30 2002-09-17 Ge-Act Communications, Inc. Method and apparatus for a cable location and protection system
SE0202133D0 (sv) * 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
SE0302755D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel compounds
US20070021498A1 (en) * 2004-10-14 2007-01-25 Nafizal Hossain Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
SE0302811D0 (sv) * 2003-10-23 2003-10-23 Astrazeneca Ab Novel compounds
SE0303090D0 (sv) * 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303280D0 (sv) * 2003-12-05 2003-12-05 Astrazeneca Ab Novel compounds
SE0303541D0 (sv) * 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
TW200821316A (en) * 2006-07-19 2008-05-16 Astrazeneca Ab Novel compounds 243

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962259A (en) * 1973-12-12 1976-06-08 American Hoechst Corporation 1,3-Dihydrospiro[isobenzofuran]s and derivatives thereof
US3959475A (en) * 1973-12-12 1976-05-25 American Hoechst Corporation Substituted 1,3-dihydrospiro(isobenzofuran)s
US4031224A (en) * 1976-04-29 1977-06-21 American Hoechst Corporation 1,3-Dihydro-heteroarylspiro (isobenzofuran)s

Also Published As

Publication number Publication date
ES8202810A1 (es) 1982-03-01
ES501421A0 (es) 1982-02-16
ES8203872A1 (es) 1982-04-01
ES8203084A1 (es) 1982-02-16
ES501420A0 (es) 1982-02-16
ES8203082A1 (es) 1982-02-16
ES501423A0 (es) 1982-02-16
ES8202809A1 (es) 1982-03-01
JPS5645469A (en) 1981-04-25
ES8203085A1 (es) 1982-02-16
EP0027522A1 (en) 1981-04-29
US4263317A (en) 1981-04-21
ES8203083A1 (es) 1982-02-16
ES501419A0 (es) 1982-04-01
ES501422A0 (es) 1982-03-01
ES501424A0 (es) 1982-02-16
ES8106512A1 (es) 1981-07-16
ES501418A0 (es) 1982-03-01

Similar Documents

Publication Publication Date Title
ES491534A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol.
ES514868A0 (es) "un procedimiento para la preparacion de un derivado de tiazol".
ES494690A0 (es) Un procedimiento para la preparacion de espiro (ciclohexano-1.1'(3'h)-isobenzofuranos)
ES511835A0 (es) "procedimiento para la preparacion de nuevas piriimidinonas".
ES512076A0 (es) "un procedimiento para la preparacion de piridin- y piracin-derivados".
ES494131A0 (es) Un procedimiento para la preparacion de diariltiofenos.
ES491944A0 (es) Un procedimiento para la preparacion de tienamicinas.
ES491835A0 (es) Un procedimiento para la preparacion de mono-y-di-esteres desacarosa.
ES512914A0 (es) "procedimiento para la preparacion de nuevas fenilalcohilaminas".
ES515295A0 (es) "un procedimiento para la preparacion de imidazoquinazolinas".
ES496486A0 (es) Un procedimiento para la preparacion de nuevos 1,2,4-triazo-les
ES512079A0 (es) "un procedimiento para la preparacion de nuevos acilderivados de cefalosporina".
ES492115A0 (es) Un procedimiento para la preparacion de 10, 11-dihidro-5-h- dibenzo (a,d) ciclohepten -5,10-iminas
ES490277A0 (es) Un procedimiento para la preparacion de aminoeteres.
ES510286A0 (es) "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas".
ES514572A0 (es) "un procedimiento para la preparacion de glutation".
ES508152A0 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
ES514571A0 (es) "un procedimiento para la preparacion de glutation".
ES510928A0 (es) "un procedimiento para la preparacion de mercapto-acil-carnitinas".
ES513832A0 (es) "un procedimiento para la preparacion de fenetilpiperidinas".
ES508723A0 (es) "un procedimiento para la preparacion de derivados de metoxicefalosporinas".
ES489469A0 (es) Un procedimiento para la preparacion de 1, 1'-bifenil-2-il- alquilamina.
ES491136A0 (es) Un procedimiento para la preparacion de imidazo-piridinas.
ES504525A0 (es) Un procedimiento para la preparacion de pirrolo (3,4-d)(2) benzacepinas
ES494205A0 (es) Un procedimiento para la preparacion de nuevas tricloropropilureas.